2Machens K, Schmidt - Gollwitzer K. Issues to debate on the Women's Health Initiative (WHI) study. Hormone Replacment therapy: an epidemiological diemma[J] ? Human Reproduction, 2003, 18 (10) : 1992.
3Rymer J, Wilson R, Ballard K. Making decisions about hormone replacement therapy [J].BMJ, 2003, 326:322.
4Ahmed M, Raafat PD, Lome Jet al. Proliferative effects of combination estrogen and progesterone replacement therapy on the normal postmenopausal mammary gland in a murine model[J]. Am J Obstet gynecol, 2001, 184 (2): 340.
5Gambacciani M, Mnteleone P, Sacco A et al. hormone replacement therapy and endometrial ovarian and colorect cancer [J]. Best Pract Res Clin Endocrinol Metab, 2003, 17:139.
6Verheul HAM, Coelingh -Bennink HJT, Kenemans Pet al. Effects of estrogens and hormone replacement therapy on breast cancer risk and on efficacy of breast cancer therapies [J]. Maturitas, 2000, 36:1.
7Delgado RL, Lubian Lopez DM. Prognosis of breast cancers detected in women receiving hormone replacement therapy [J]. Maturitas, 2001, 38:147.
8Machens K, Schmidt-Gollwitzer K. Issues to debate on the Women's Health Initiative (WHI)study. Hormone Replacment therapy:an epidemiological diemma[J]? Human Reproduction,2003,18(10):1992-1999.
9Rymer J, Wilson R, Ballard K. Making decisions about hormone replacement therapy[J]. BMJ, 2003,326:322-326.
10Ahmed M, Raafat PD, Lorne J, et al. Proliferative effects of combination estrogen and progesterone replacement therapy on the normal postmenopausal mammary gland in a murine model[J]. Am J Obstet Gynecol,2001,184(2):340-349.
